Join
Live feed
·
PRReleasevia Quantisnow
Indivior Pharmaceuticals Inc. logo

New Study Shows Adherence to Monthly Injectable Buprenorphine Linked to Lower Healthcare Utilization and Costs in Opioid Use Disorder

ByQuantisnow·Wall Street's wire, on your screen.
INDV· Indivior Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INDV (Indivior Pharmaceuticals Inc.) and more on Quantisnow.